Key Takeaways
- Shares of MRAM reached an annual peak of $23.10 on May 8, closing near $22.59 with approximately 437,000 shares traded
- The company secured a decade-long production agreement with Microchip Technology for domestic MRAM manufacturing expansion in Oregon
- First quarter earnings per share of $0.11 on $14.87M revenue exceeded Wall Street’s $14.60M projection
- Second quarter 2026 earnings forecast of $0.000–$0.030 per share reflects conservative near-term expectations; analyst rating consensus is Hold at $18.50 average price target
- Top executives liquidated approximately $796K in company shares during early May
Shares of Everspin Technologies (MRAM) surged to an annual high of $23.10 during Friday’s trading session on May 8, ultimately closing near $22.59. This represents a significant premium over both the 50-day moving average of $11.18 and the 200-day moving average of $10.63.
Everspin Technologies, Inc., MRAM
Trading activity surged to approximately 437,000 shares, exceeding typical volume levels, with the previous session’s close at $21.51.
The equity has appreciated roughly 25% in recent weeks, primarily fueled by a strategic manufacturing collaboration unveiled last month.
Strategic Partnership With Microchip Technology
Everspin revealed on April 8 a comprehensive 10-year collaboration with Microchip Technology focused on manufacturing MRAM and Tunnel Magnetoresistive (TMR) sensor solutions at Microchip’s fabrication plant in Oregon.
Under this arrangement, Everspin retains complete ownership of its intellectual property and manufacturing processes. The partnership also introduces ITAR-compliant wafer fabrication capabilities, a critical requirement for aerospace and defense sector clients.
Operations at Everspin’s current Chandler, Arizona manufacturing site will continue alongside the new Oregon facility. Initial product shipments from the Oregon production line are anticipated during the latter half of 2027.
The partnership includes provisions for renewal in two-year intervals following the conclusion of the initial decade-long commitment.
Strong Quarter, But Conservative Forward Outlook
The company delivered first quarter 2026 earnings of $0.11 per share alongside revenue totaling $14.87 million, surpassing analyst projections of $14.60 million.
Profit margin stood at 0.50% while return on equity registered at 4.78%.
Looking ahead to Q2 2026, management provided a notably conservative forecast. Projected earnings per share of $0.000 to $0.030 represent a broad and modest range, indicating management’s cautious near-term perspective.
Current market capitalization stands at $593 million, accompanied by a price-to-earnings ratio of 2,532 — underscoring the nascent stage of the company’s profit generation trajectory.
Mixed Signals From Analysts and Company Insiders
Wall Street opinion remains divided. Needham elevated its price objective from $14.00 to $18.50 while reaffirming a Buy recommendation on April 30. Weiss Ratings maintained its Sell stance in March. Wall Street Zen shifted its rating from Buy to Hold in February.
Overall analyst sentiment converges at Hold with a mean price target of $18.50 — substantially below current trading levels.
Regarding insider transactions, CEO Sanjeev Aggarwal divested 28,459 shares at $19.58 per share on May 4, generating approximately $557,000. This transaction reduced his ownership position by 3.36%.
CFO William Earl Cooper sold 11,000 shares at $21.75 on May 6, collecting $239,250 — representing a 6.39% decrease in his holdings.
Collectively, company insiders have sold approximately 60,448 shares valued at roughly $990,000 throughout the previous three-month period.
Institutional investors control 44.68% of outstanding shares, with multiple hedge funds establishing fresh positions during recent quarters, including Raymond James Financial, Kestra Advisory Services, and Occudo Quantitative Strategies.
The stock’s beta coefficient of 1.75 indicates above-average price volatility relative to the overall market.
